The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Empowering young-onset colorectal cancer patients with an accessible, self-navigable online platform for universal germline testing.
 
Julie Moskowitz
No Relationships to Disclose
 
Maureen Mork
No Relationships to Disclose
 
Elaine Maghanoy
No Relationships to Disclose
 
Sa Nguyen
No Relationships to Disclose
 
Devon Harrison
No Relationships to Disclose
 
Kelly Lovero
No Relationships to Disclose
 
Prajnan Das
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - American Society for Radiation Oncology
 
George Chang
Consulting or Advisory Role - GlaxoSmithKline; Iota Biosciences; Medicaroid; Medtronic
 
Selvi Thirumurthi
No Relationships to Disclose
 
Luigi Ricciardiello
Consulting or Advisory Role - Karger publisher
(OPTIONAL) Uncompensated Relationships - SLA Pharma
 
Eduardo Vilar Sanchez
Consulting or Advisory Role - Abbvie; Guardant Health; Janssen Research & Development; Nouscom; Recursion Pharmaceuticals; Rising Tide Foundation
Research Funding - Janssen Research & Development; Nouscom
Patents, Royalties, Other Intellectual Property - The University of Texas MD Anderson Cancer Center, Vilar E, Chang K, Wu W, Bowen CM, Sinha K. Methods and Compositions Comprising MHC Class I Peptides, United States, 63/171,137, 4/6/2021, Filed (Provisional); The University of Texas MD Anderson Cancer Center, Vilar E, Wu W, Katayama H, Hanash S, Bommi P. Methods for Prognosing, Diagnosing, and Treating Colorectal Cancer, United States, 63/152,751, 2/23/2021, Filed (Provisional)
Travel, Accommodations, Expenses - Guardant Health; Janssen Research & Development
 
Y. Nancy You
No Relationships to Disclose